These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
754 related articles for article (PubMed ID: 33535692)
1. IgM and IgG Profiles Reveal Peculiar Features of Humoral Immunity Response to SARS-CoV-2 Infection. De Donno A; Lobreglio G; Panico A; Grassi T; Bagordo F; Bozzetti MP; Massari S; Siculella L; Damiano F; Guerra F; Greco M; Chicone M; Lazzari R; Alifano P Int J Environ Res Public Health; 2021 Feb; 18(3):. PubMed ID: 33535692 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19. Wu J; Liang B; Chen C; Wang H; Fang Y; Shen S; Yang X; Wang B; Chen L; Chen Q; Wu Y; Liu J; Yang X; Li W; Zhu B; Zhou W; Wang H; Li S; Lu S; Liu D; Li H; Krawczyk A; Lu M; Yang D; Deng F; Dittmer U; Trilling M; Zheng X Nat Commun; 2021 Mar; 12(1):1813. PubMed ID: 33753738 [TBL] [Abstract][Full Text] [Related]
3. Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients. Cheng L; Zhang X; Chen Y; Wang D; Zhang D; Yan S; Wang H; Xiao M; Liang T; Li H; Xu M; Hou X; Dai J; Wu X; Li M; Lu M; Wu D; Tian R; Zhao J; Zhang Y; Cao W; Wang J; Yan X; Zhou X; Liu Z; Xu Y; He F; Li Y; Yu X; Zhang S Signal Transduct Target Ther; 2021 Aug; 6(1):304. PubMed ID: 34404759 [TBL] [Abstract][Full Text] [Related]
4. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples. Mazzini L; Martinuzzi D; Hyseni I; Benincasa L; Molesti E; Casa E; Lapini G; Piu P; Trombetta CM; Marchi S; Razzano I; Manenti A; Montomoli E J Immunol Methods; 2021 Feb; 489():112937. PubMed ID: 33253698 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience. Infantino M; Grossi V; Lari B; Bambi R; Perri A; Manneschi M; Terenzi G; Liotti I; Ciotta G; Taddei C; Benucci M; Casprini P; Veneziani F; Fabbri S; Pompetti A; Manfredi M J Med Virol; 2020 Sep; 92(9):1671-1675. PubMed ID: 32330291 [TBL] [Abstract][Full Text] [Related]
6. Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan. Nakano Y; Kurano M; Morita Y; Shimura T; Yokoyama R; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y Sci Rep; 2021 Feb; 11(1):2776. PubMed ID: 33531605 [TBL] [Abstract][Full Text] [Related]
7. Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI. Selingerova I; Valik D; Gescheidtova L; Sramek V; Cermakova Z; Zdrazilova-Dubska L J Med Virol; 2021 Mar; 93(3):1805-1809. PubMed ID: 33079389 [TBL] [Abstract][Full Text] [Related]
8. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. Li Z; Yi Y; Luo X; Xiong N; Liu Y; Li S; Sun R; Wang Y; Hu B; Chen W; Zhang Y; Wang J; Huang B; Lin Y; Yang J; Cai W; Wang X; Cheng J; Chen Z; Sun K; Pan W; Zhan Z; Chen L; Ye F J Med Virol; 2020 Sep; 92(9):1518-1524. PubMed ID: 32104917 [TBL] [Abstract][Full Text] [Related]
9. Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity. Wu J; Liang BY; Fang YH; Wang H; Yang XL; Shen S; Chen LK; Li SM; Lu SH; Xiang TD; Liu J; Le-Trilling VTK; Lu MJ; Yang DL; Deng F; Dittmer U; Trilling M; Zheng X Front Immunol; 2021; 12():722027. PubMed ID: 34489971 [TBL] [Abstract][Full Text] [Related]
10. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies. Guo X; Zeng L; Huang Z; He Y; Zhang Z; Zhong Z Front Immunol; 2020; 11():1936. PubMed ID: 32849650 [No Abstract] [Full Text] [Related]
11. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak. Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214 [TBL] [Abstract][Full Text] [Related]
12. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic. Canetti D; Dell'Acqua R; Riccardi N; Della Torre L; Bigoloni A; Muccini C; Bruzzesi E; Ranzenigo M; Chiurlo M; Racca S; Galli C; Castagna A; Tambussi G; Lazzarin A New Microbiol; 2020 Oct; 43(4):161-165. PubMed ID: 33135083 [TBL] [Abstract][Full Text] [Related]
14. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152 [TBL] [Abstract][Full Text] [Related]
15. Development of SARS-CoV-2 IgM and IgG antibodies in a relapsing multiple sclerosis patient on ofatumumab. Flores-Gonzalez RE; Hernandez J; Tornes L; Rammohan K; Delgado S Mult Scler Relat Disord; 2021 Apr; 49():102777. PubMed ID: 33508573 [TBL] [Abstract][Full Text] [Related]
16. Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Qu J; Wu C; Li X; Zhang G; Jiang Z; Li X; Zhu Q; Liu L Clin Infect Dis; 2020 Nov; 71(16):2255-2258. PubMed ID: 32337590 [TBL] [Abstract][Full Text] [Related]
17. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays. Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042 [TBL] [Abstract][Full Text] [Related]
18. Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients. Tajuelo A; Carretero O; García-Ríos E; López-Siles M; Cano O; Vázquez M; Más V; Rodríguez-Goncer I; Lalueza A; López-Medrano F; Juan RS; Fernández-Ruiz M; Aguado JM; McConnell MJ; Pérez-Romero P Front Immunol; 2022; 13():878812. PubMed ID: 35547738 [TBL] [Abstract][Full Text] [Related]
19. Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays. Qian C; Zhou M; Cheng F; Lin X; Gong Y; Xie X; Li P; Li Z; Zhang P; Liu Z; Hu F; Wang Y; Li Q; Zhu Y; Duan G; Xing Y; Song H; Xu W; Liu BF; Xia F Clin Chem Lab Med; 2020 Aug; 58(9):1601-1607. PubMed ID: 32609640 [TBL] [Abstract][Full Text] [Related]
20. Value and Validity of Coronavirus Antibody Testing. Mahajan A; Manchikanti L Pain Physician; 2020 Aug; 23(4S):S381-S390. PubMed ID: 32942795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]